In the pathway networks of PBDE-treated HepG2 cells, EGFR appeared at the crossroad of HIF-1 and estrogen signaling for BDE-47 and was shared by prostate cancer and adherens junction pathways for BDE-209. The gene discussed is EGFR; the disease is prostate carcinoma.